1. Home
  2. IGC vs OPAD Comparison

IGC vs OPAD Comparison

Compare IGC & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • OPAD
  • Stock Information
  • Founded
  • IGC 2005
  • OPAD 2015
  • Country
  • IGC United States
  • OPAD United States
  • Employees
  • IGC N/A
  • OPAD N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • OPAD Real Estate
  • Sector
  • IGC Health Care
  • OPAD Finance
  • Exchange
  • IGC Nasdaq
  • OPAD Nasdaq
  • Market Cap
  • IGC 33.5M
  • OPAD 37.9M
  • IPO Year
  • IGC N/A
  • OPAD N/A
  • Fundamental
  • Price
  • IGC $0.37
  • OPAD $1.43
  • Analyst Decision
  • IGC Strong Buy
  • OPAD Hold
  • Analyst Count
  • IGC 2
  • OPAD 5
  • Target Price
  • IGC $3.88
  • OPAD $2.41
  • AVG Volume (30 Days)
  • IGC 862.4K
  • OPAD 2.7M
  • Earning Date
  • IGC 08-14-2025
  • OPAD 08-04-2025
  • Dividend Yield
  • IGC N/A
  • OPAD N/A
  • EPS Growth
  • IGC N/A
  • OPAD N/A
  • EPS
  • IGC N/A
  • OPAD N/A
  • Revenue
  • IGC $1,327,000.00
  • OPAD $703,352,000.00
  • Revenue This Year
  • IGC $15.26
  • OPAD N/A
  • Revenue Next Year
  • IGC $3.41
  • OPAD $40.79
  • P/E Ratio
  • IGC N/A
  • OPAD N/A
  • Revenue Growth
  • IGC 24.95
  • OPAD N/A
  • 52 Week Low
  • IGC $0.25
  • OPAD $0.91
  • 52 Week High
  • IGC $0.48
  • OPAD $5.13
  • Technical
  • Relative Strength Index (RSI)
  • IGC 57.43
  • OPAD 50.09
  • Support Level
  • IGC $0.35
  • OPAD $0.97
  • Resistance Level
  • IGC $0.37
  • OPAD $1.44
  • Average True Range (ATR)
  • IGC 0.02
  • OPAD 0.23
  • MACD
  • IGC -0.00
  • OPAD -0.01
  • Stochastic Oscillator
  • IGC 79.80
  • OPAD 63.13

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

Share on Social Networks: